Global Thermal Ablation Market Research Report
- Report Code: TH 1000
- Publish Date: Upcoming
The Global Thermal Ablation Market, mainly driven by increasing aging population with high risk of chronic diseases and increasing procedures through minimal invasive surgery was valued at $9386 million in 2013 and is expected to reach $15480 million by 2018. The Radiation market is the largest segment of $3735 million of Thermal Ablation Market.
The report “Thermal Ablation Market forecast, 2008-2018” analyzes the market of devices by 7 segments such as Electrical, Radiation, Radiofrequency, Light, Ultrasound, Microwave, and Hydrothermal Ablation. All of these segments experienced a positive growth till 2012 with an increased awareness of patients and physicians towards the usage and reception of new thermal ablation technologies due to the numerous advantages offered by these devices.
Older population is growing in the mature markets such as Japan, U.S. and in the Western European countries. Currently, one quarter of the Japanese population is aged 65 and older. Currently, in the U.S., 40 million people are aged 65 and above and it is expected that by 2050 this number will increase to 89 million. The diseases such as cancer, cardiovascular disorders, gynecological, and orthopedic problems are on the rise. As the number of patient population will increase it will lead to increase in the procedural volume of minimally invasive surgeries, ultimately giving rise to increased demand for thermal ablation devices.
Emerging markets such as India, China, and Brazil have undergone significant economic development over the past decade. This development has also led to an increase in healthcare availability in these countries. Also, as these countries have relatively modest GDP per capita levels and highly variable healthcare systems, the need for inexpensive thermal ablation devices is emerging as an important factor. It has provided an opportunity for thermal ablation devices companies, to have an established and growing market in these countries.
European market is challenging, as it is a heterogeneous region in terms of regulatory and reimbursement approaches, with every country having its own unique characteristics. Aging Japanese population, which is at a high risk of developing chronic diseases such as cancer and cardiac disorders, will ultimately lead to growth in procedure volume in the future of thermal ablation market.
The report also provides an extensive competitive landscaping of companies operating in thermal ablation market. The main companies operating in thermal ablation market are Varian Medical systems, Elekta, Biosense Webster, St. Jude Medical Boston Scientfic, Accuray, Medtronic, CR Bard, others.
Segment and country specific Company shares, News & Deals, M&A, segment specific pipeline products, product approvals and product recalls of the major companies in thermal ablation market have been detailed.
Customization Options:
The market data enables you to customize the MMM assessments that meet your company’s specific needs. Customize to get comprehensive industry standard and deep dive analysis of the following parameters:
Product Analysis
- Usage pattern (in-depth trend analysis) of products (Segment wise)
- Product Matrix which gives a detailed comparison of product portfolio of each company mapped at country and sub segment level
- End-user Adoption rate analysis of the products (Segment wise and Country wise)
- Comprehensive coverage of Product approvals, Pipeline products and Product recalls
Epidemiology Data
- Country specific Prevalence of cancer and cardiovascular disorders
- Country specific Patient pool of cancer and cardiovascular disorders
- Disease progression (Pattern analysis)
Surgeons/Physicians Perception Analysis
- Fast turn-around analysis of Surgeons response to market events and trends
- Surgeons opinion about products from different companies
- Surgeons qualitative inputs on epidemiology date
Brand/Product Perception Matrix
- Comprehensive study of customers perception and behavior through our inbuilt social connect tool checking the virality and tonality of blogs
- Analysis of overall brand usage and familiarity and brand advocacy distribution (Detractor/Neutral/Familiar)
1 Introduction
1.1 Analyst Insights
1.2 Market Definitions
1.3 Market Segmentation & Aspects Covered
1.4 Research Methodology
2 Executive Summary
3 Market Overview
4 By Products
4.1 Radiation
5 By Technologies
5.1 Electrical Ablation
5.2 Radiation Ablation
5.3 Radiofrequency Ablation
5.4 Hydrothermal Ablation
5.5 Light Ablation
5.6 Microwave Ablation
5.7 Ultrasound Ablation
6 By Geographies
6.1 North America
6.2 Europe
6.3 Asia
6.4 Rest of World
Please fill in the form below to receive a free copy of the Summary of this Report
Please visit http://www.micromarketmonitor.com/custom-research-services.html to specify your custom Research Requirement
| PRODUCT TITLE | PUBLISHED | |
|---|---|---|
|
|
Microwave Ablation The Global Microwave Ablation Market was pegged at $120 million in 2013 and expected to be $201 million by 2018. Microwave thermotherapy is the technology employed in Microwave Ablation. Currently there are very few players in microwave ablation market, major players being Synapse Medical, Microsilus Medical (U.K.) which recently entered into a strategic partnership with Angiodynamics (U.S). |
Upcoming |
|
|
Ultrasound Ablation The Global Ultrasound Ablation Market was pegged at $1243 million in 2013 and expected to be $2282 million by 2018. The key players in ultrasound ablation segment are InSightec(U.S), Elmed Lithotripsy(Turkey), Ethicon (J&J)(U.S), Misonix Inc.(U.S), USHIFU (U.S.), and Sonora (U.S.), a subsidiary of Misonix. |
Upcoming |
|
|
Electrical Ablation The Global Electrical Ablation Market was pegged at $867 million in 2013 and expected to be $1098 million by 2018. In electrical ablation market, electrical ablators accounted for a share of 90.4% in 2011. The main companies operating in this market and extensively covered in this report are ConMed Corporation (U.S), Medtronic (U.S), Boston Scientific (U.S), Angiodynamics (U.S), and Covidien (Ireland). |
Upcoming |
|
|
Hydrothermal Ablation The Global Hydrothermal Ablation Market, mainly driven by increasing aging population with higher risk of chronic diseases and increasing procedures through minimal invasive surgery. An endometrial hydrothermal balloon ablation device is the major technology indulged in hydrothermal ablation market. The main companies operating in hydrothermal ablation market and extensively covered in this report are Varian Medical systems, Elekta, Biosense Webster, St. Jude Medical Boston Scientfic, Accuray, Medtronic, CR Bard, Others. |
Upcoming |
|
|
Light/Laser Ablation The Global Light/Laser Ablation Market, was pegged at $1183 million in 2013 and expected to be $1859 million by 2018. The light/laser ablation devices consist of two types of lasers namely, cold lasers and excimer lasers. The key players operating in the optical correction Light/Laser ablation are Alcon, Abbott, Carl Zeiss followed by others. |
Upcoming |
|
|
Radiation Ablation The Global Radiation Ablation Market was pegged at $3735 million in 2013 and expected to be $5537 million by 2018. In terms of volume, the stereotactic radiotherapy and radiosurgery devices accounted for the largest volume in sales.The main companies operating in this market and extensively covered in this report are Varian Medical Systems (U.S), and Elekta (Sweden). |
Upcoming |
|
|
Radiofrequency Ablation The Global Radiofrequency Ablation Market was pegged at $1918 million in 2013 and expected to be $3854 million by 2018. This report also provides an extensive competitive landscaping of companies operating in radiofrequency ablation market. The key players in radiofrequency ablation market are Covidien (Ireland), Boston Scientific (U.S.), Biosense Inc. (U.S.), St. Jude Medical (U.S.), AngioDynamics (U.S.) and Medtronic Inc. (U.S.). |
Upcoming |
|
|
Americas Electrical Ablation The American Electrical Ablation Market was pegged at $387 million in 2013 and expected to be $480 million by 2018,. In electrical ablation market, electrical ablators accounted for a share of 90.4% in 2011. The main companies operating in electrical ablation market are ConMed Corporation (U.S), Medtronic (U.S), Boston Scientific (U.S), Angiodynamics (U.S), and Covidien (Ireland). |
Upcoming |
|
|
Asia-Pacific Electrical Ablation The Asia-Pacific electrical ablation market was valued at $159.0 million in 2013 and is expected to reach $236.0 million by 2018. In the electrical ablation market, electrical ablators accounted for a share of 90.4% in 2011. The main companies operating in Asia-Pacific Electrical Ablation market and extensively covered in this report are ConMed Corporation (U.S), Medtronic (U.S), Boston Scientific Corporation (U.S), AngioDynamics (U.S), and Covidien plc (Ireland). |
Upcoming |
|
|
European Electrical Ablation The European electrical ablation market was valued at $189.0 million in 2013 and is expected to reach $228.0 million by 2018. In the European electrical ablation market, electrical ablators accounted for a share of 90.4% in 2011. The main companies operating in this market and extensively covered in this report are ConMed Corporation (U.S), Medtronic (U.S), Boston Scientific Corporation (U.S), AngioDynamics (U.S), and Covidien plc (Ireland). |
Upcoming |
|
|
Americas Hydrothermal Ablation The American Hydrothermal Ablation Market, mainly driven by growing aging population, with increasing incidence, and prevalence of chronic diseases such as cancer and cardiovascular disorders, rapid acceptance of new medical technology, and well covered reimbursement system. The main companies operating in hydrothermal ablation market and extensively covered in this report are Varian Medical systems, Elekta, Biosense Webster, St. Jude Medical Boston Scientfic, Accuray, Medtronic, CR Bard, Others |
Upcoming |
|
|
Asia-Pacific Hydrothermal Ablation The Asia-Pacific Hydrothermal Ablation Market, mainly driven by increasing aging population with higher risk of chronic diseases and increasing age related chronic diseases. The main companies operating in Hydrothermal Ablation market and extensively covered in this report are Varian Medical systems, Elekta, Biosense Webster, St. Jude Medical Boston Scientfic, Accuray, Medtronic, CR Bard, Others. |
Upcoming |
|
|
European Hydrothermal Ablation The European Hydrothermal Ablation Market, mainly driven by increasing aging population with higher risk of chronic diseases and increasing age related chronic diseases. The main companies operating in Hydrothermal Ablation market and extensively covered in this report are Varian Medical systems, Elekta, Biosense Webster, St. Jude Medical Boston Scientfic, Accuray, Medtronic, CR Bard, Others. |
Upcoming |
|
|
Americas Light/Laser Ablation The American Light/Laser Ablation Market, was pegged at $347 million in 2013 and expected to be $527 million by 2018. The Excimer Laser market is the largest segment of Light/Laser Ablation Market. The key players operating in the optical correction Light/Laser ablation are Alcon, Abbott, Carl Zeiss followed by others. |
Upcoming |
|
|
Asia-Pacific Light/Laser Ablation The Asia-Pacific Light/Laser Ablation Market was pegged at $192 million in 2013 and expected to be $330 million by 2018. The Excimer Laser market is the largest segment of Light/Laser Ablation Market. The key players operating in the optical correction Light/Laser ablation are Alcon, Abbott, Carl Zeiss followed by others. |
Upcoming |
|
|
European Light/Laser Ablation The European Light/Laser Ablation Market was pegged at $298 million in 2013 and expected to be $450 million by 2018. The Excimer Laser market is the largest segment of Light/Laser Ablation Market. The key players operating in the optical correction Light/Laser ablation are Alcon, Abbott, Carl Zeiss followed by others. |
Upcoming |
|
|
Americas Microwave Ablation The American Microwave Ablation Market was pegged at $75 million in 2013 and expected to be $133 million by 2018. Currently there are very few players in microwave ablation market, major players being Synapse Medical, Microsilus Medical (U.K.) which recently entered into a strategic partnership with Angiodynamics (U.S). |
Upcoming |
|
|
Asia-Pacific Microwave Ablation The Asia-Pacific Microwave Ablation Market was pegged at $15 million in 2013 and expected to be $31 million by 2018. Currently there are very few players in the Asia-Pacific Microwave Ablation market, major players being Synapse Medical, Microsilus Medical (U.K.) which recently entered into a strategic partnership with Angiodynamics (U.S). |
Upcoming |
|
|
European Microwave Ablation The European Microwave Ablation Market was pegged at $27 million in 2013 and expected to be $45 million by 2018. Currently there are very few players in European Microwave Ablation market, major players being Synapse Medical, Microsilus Medical (U.K.) which recently entered into a strategic partnership with Angiodynamics (U.S). |
Upcoming |
|
|
Americas Radiation Ablation The American Radiation Ablation Market, mainly driven by growing aging population, with increasing incidence, and prevalence of chronic diseases such as cancer and cardiovascular disorders, rapid acceptance of new medical technology, and well covered reimbursement system. The main companies operating in radiation ablation market and extensively covered in this report are Varian Medical Systems (U.S), and Elekta (Sweden). |
Upcoming |
